Home
Scholarly Works
MCL-373 Unmet Need in Relapsed/Refractory (RR)...
Journal article

MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis

Authors

Dreyling M; Shah B; Wu J; Itani T; Zoratti M; Kanters S; Wade S; Peng W; Castaigne J-G; Kloos I

Journal

Clinical Lymphoma Myeloma & Leukemia, Vol. 23, , pp. s461–s462

Publisher

Elsevier

Publication Date

September 1, 2023

DOI

10.1016/s2152-2650(23)01377-0

ISSN

2152-2650

Contact the Experts team